Etoricoxib
- ₹7308 - ₹9785.8
- Product name: Etoricoxib
- CAS: 202409-33-4
- MF: C18H15ClN2O2S
- MW: 358.84
- EINECS:682-421-5
- MDL Number:MFCD06797512
- Synonyms:Etoricoxib Solution, 100ppm;Etoricoxib(5-chloro-6'-Methyl-3-(4-(Methylsulfonyl)phenyl)-2,3'-bipyridine;Etoricoxib (200 mg);Etoricoxib impurity A;Etoricoxib, >=98%;5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine;ETORICOXIB;5-Chloro-6'-methyl-3-[4-(methylsulfonyl) phenyl]-2,3'-bipyridine
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
- ottokemi
Package
- 25MG
- ManufacturerSigma-Aldrich(India)
- Product number32097
- Product descriptionEtoricoxib VETRANAL?, analytical standard
- Packaging25MG
- Price₹9785.8
- Updated2022-06-14
- Buy
- Manufacturerottokemi
- Product number E 0687
- Product descriptionEtoricoxib, ≥98%
- Packaging25mg
- Price₹7308
- Updated2022-05-26
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | 32097 | Etoricoxib VETRANAL?, analytical standard | 25MG | ₹9785.8 | 2022-06-14 | Buy |
ottokemi | E 0687 | Etoricoxib, ≥98% | 25mg | ₹7308 | 2022-05-26 | Buy |
Properties
Melting point :134-135°C
Boiling point :510.0±50.0 °C(Predicted)
Density :1.298±0.06 g/cm3(Predicted)
storage temp. :Inert atmosphere,2-8°C
solubility :DMSO : 100 mg/mL (278.68 mM; Need ultrasonic)
pka :4.5(at 25℃)
form :Solid
color :Light yellow to yellow
BRN :8073797
InChIKey :MNJVRJDLRVPLFE-UHFFFAOYSA-N
CAS DataBase Reference :202409-33-4(CAS DataBase Reference)
Boiling point :510.0±50.0 °C(Predicted)
Density :1.298±0.06 g/cm3(Predicted)
storage temp. :Inert atmosphere,2-8°C
solubility :DMSO : 100 mg/mL (278.68 mM; Need ultrasonic)
pka :4.5(at 25℃)
form :Solid
color :Light yellow to yellow
BRN :8073797
InChIKey :MNJVRJDLRVPLFE-UHFFFAOYSA-N
CAS DataBase Reference :202409-33-4(CAS DataBase Reference)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||
Precautionary statements: |
|
Description
Etoricoxib is a dipyridinyl compound that demonstrates high in vitro and ex vivo selectivity for COX-2 over COX-1 in several assays, e.g., in the production of PGE2 by CHO cells expressing either COX-2 (IC50 = 79 nM) or COX-1 (IC50 > 50 μM). Oral etoricoxib is well absorbed and metabolized extensively via oxidation, with metabolites excreted largely in the urine.More related product prices
Methyl sulfone Salicylazosulfapyridine Pyridine 1,5-Diphenylcarbazide CYCLAZOSIN HYDROCHLORIDE Sofosbuvir 2-(2-(((benzhydryloxy)carbonyl)amino)-6-chloro-9H-purin-9-yl)acetic acid Etofenamate Etocrilene Exemestane 3521-62-8 Gabapentin hydrochloride Naproxen Probenecid Ibuprofen Etomidate Diclofenac sodium 4052-30-6 4-Methylsulphonylphenylacetic acidRelated product price
- Methyl sulfone
₹603-14851.9 - Etoposide
₹7605-1797560.2 - Salicylazosulfapyridine
₹7700-35105.48